Dynavax to Present at Two Upcoming Investor Healthcare Conferences
(firmenpresse) - BERKELEY, CA -- (Marketwire) -- 02/14/12 -- Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that Dino Dina, M.D., Chief Executive Officer, will be presenting at the Citigroup 2012 Global Health Care Conference to be held February 27-29, and at the Cowen and Company 32nd Annual Health Care Conference being held March 5-7, 2012.
Event: Citigroup 2012 Global Health Care Conference
Date: Tuesday, February 28, 2012
Time: 8:30 AM (ET)
Place: Waldorf Astoria, New York, NY
Event: Cowen and Company 32nd Annual Health Care Conference
Date: Tuesday, March 6, 2012
Time: 10:00 AM (ET)
Place: The Boston Marriott Copley Place, Boston, MA
To access the live webcast and the subsequent archived recording of the presentations, please log onto Dynavax's website at .
Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. The Company's lead product candidate is HEPLISAV™, a Phase 3 investigational adult hepatitis B vaccine designed to provide rapid and superior protection with fewer doses than current licensed vaccines. For more information visit .
Jennifer Lew
Vice President, Finance
510-665-7217
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 14.02.2012 - 08:00 Uhr
Sprache: Deutsch
News-ID 1082722
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
BERKELEY, CA
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 70 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Dynavax to Present at Two Upcoming Investor Healthcare Conferences
"
steht unter der journalistisch-redaktionellen Verantwortung von
Dynavax Technologies (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
